Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
| Website: | www.alkermes.com |
| Email: | financial@alkermes.com |
| Main Phone: | +353 17728000 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House |
| City / Town: | Dublin |
| Country: | IRL |
| Postal Code: | 4 |
| Exchange: | NGS |
| CEO: | Richard F. Pops |
| Employees: | 2000 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 32.82 | Change $ -0.95 | Change % -2.81 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 36.85 | Ask Size 600.00 |
| Open 33.22 | High 33.66 | Low 32.26 | Prev Close 33.77 |
| Last Trade | Volume 1.3 mi | 52 Wk Hi 71.22 | 52 Wk Low 32.26 |
| Market Cap 5.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 155,382,787.00 | EPS (TTM) -0.89 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 26 | 147 |
| Number of Buys | 11 | 73 |
| Number of Sells | 15 | 74 |
| Net Activity | -15686 | 139596 |
| Last 10 Buys | Shares |
|---|---|
| David W. Anstice | 1,000 |
| Wendy L. Dixon | 1,000 |
| Mark Stejbach | 1,000 |
| Floyd E Bloom | 1,000 |
| David W. Anstice | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| James M. Frates | 1,000 |
| Paul J. Mitchell | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Michael J. Landine | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 67 | 67 | 67 | 67 |
| Low Target Price Estimate | 46 | 46 | 46 | 46 |
| Mean Target Price Estimate | 56.13 | 55.57 | 55.57 | 56.13 |
| Standard Deviation | 7.32 | 7.72 | 7.72 | 7.32 |
| Date of Most Recent Estimate | 06/06/18 | 05/22/18 | 05/22/18 | 06/06/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| CT ORDER | 1 | 2018-05-30 | |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2.11 | 2.43 | 2.33 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
